Tác động của việc tiếp xúc với methamphetamine trong thời kỳ thai nghén: một tổng quan về các nghiên cứu về nhận thức và hình ảnh não

Abar B, LaGasse LL, Wouldes T, Derauf C, Newman E, Shah R et al (2013) Cross-national comparison of prenatal methamphetamine exposure on infant and early child physical growth: a natural experiment. Prev Sci 1:1–10 Ahmadlou M, Ahmadi K, Rezazade M, Azad-Marzabadi E (2013) Global organization of functional brain connectivity in methamphetamine abusers. Clin Neurophysiol 124:1122–1131 Andersen SL (2003) Trajectories of brain development: point of vulnerability or window of opportunity? Neurosci Biobehav Rev 27:3–18 Barr AM, Panenka WJ, MacEwan GW, Thornton AE, Lang DJ, Honer WG, Lecomte T (2006) The need for speed: an update on methamphetamine addiction. J Psychiatry Neurosci 31:301–313 Behnke M, Smith VC, Levy S, Ammerman SD, Gonzalez PK, Ryan SA et al (2013) Prenatal substance abuse: short-and long-term effects on the exposed fetus. Pediatrics 131:1009–1024 Billing L, Eriksson M, Larsson G, Zetterström R (1980) Amphetamine addiction and pregnancy. Acta Paediatr 69:675–680 Billing L, Eriksson M, Steneroth G, Zetterström R (1988) Predictive indicators for adjustment in 4-year-old children whose mothers used amphetamine during pregnancy. Child Abuse Negl 12:503–507 Billing L, Eriksson M, Jonsson B, Steneroth G, Zetterström R (1994) The influence of environmental factors on behavioural problems in 8-year-old children exposed to amphetamine during fetal life. Child Abuse Negl 18:3–9 Brown JM, Hanson GR, Fleckenstein AE (2001) Regulation of the vesicular monoamine transporter-2: a novel mechanism for cocaine and other psychostimulants. J Pharmacol Exp Ther 296:762–767 Bubenikova-Valesova V, Kacer P, Syslova K, Rambousek L, Janovsky M, Schutova B et al (2009) Prenatal methamphetamine exposure affects the mesolimbic dopaminergic system and behavior in adult offspring. Int J Dev Neurosci 27:525–530 Cadet JL, Krasnova IN (2009) Molecular bases of methamphetamine-induced neurodegeneration. Int Rev Neurobiol 88:101–119 Cass WA (1997) Decreases in evoked overflow of dopamine in rat striatum after neurotoxic doses of methamphetamine. J Exp Ther 280:105–113 Cernerud L, Eriksson M, Jonsson B, Steneroth G, Zetterstrom R (1996) Amphetamine addiction during pregnancy: 14-year follow-up of growth and school performance. Acta paediatrica 85:204–208 Chang L, Smith LM, LoPresti C, Yonekura ML, Kuo J, Walot I, Ernst T (2004) Smaller subcortical volumes and cognitive deficits in children with prenatal methamphetamine exposure. Psychiatry Res Neuroimaging 132:95–106 Chang L, Alicata D, Ernst T, Volkow N (2007) Structural and metabolic brain changes in the striatum associated with methamphetamine abuse. Addiction 102:16–32 Chang L, Cloak C, Jiang CS, Farnham S, Tokeshi B, Buchthal S et al (2009) Altered neurometabolites and motor integration in children exposed to methamphetamine in utero. Neuroimage 48:391–397 Cloak CC, Ernst T, Fujii L, Hedemark B, Chang L (2009) Lower diffusion in white matter of children with prenatal methamphetamine exposure. Neurology 72:2068–2075 Cruickshank CC, Dyer KR (2009) A review of the clinical pharmacology of methamphetamine. Addiction 104:1085–1099 Cui C, Sakata Haga H, Ohta KI, Nishida M, Yashiki M, Sawada K, Fukui Y (2006) Histological brain alterations following prenatal methamphetamine exposure in rats. Congenit Anom 46:180–187 Cummings JL (1993) Frontal-subcortical circuits and human behavior. Arch Neurol 50:873 Degenhardt L, Hall W (2012) Extent of illicit drug use and dependence, and their contribution to the global burden of disease. Lancet 375:55–70 Della Grotta S, LaGasse LL, Arria AM, Derauf C, Grant P, Smith LM et al (2010) Patterns of methamphetamine use during pregnancy: results from the Infant Development, Environment, and Lifestyle (IDEAL) Study. Matern Child Health J 14:519–527 Eriksson M, Zetterström R (1994) Amphetamine addiction during pregnancy: 10-year follow-up. Acta Paediatr 83:27–31 Eriksson M, Larsson G, Winbladh B, Zetterström R (1978) The influence of amphetamine addiction on pregnancy and the newborn infant. Acta paediatrica Scandinavica 67:95 Eriksson M, Larsson G, Zetterström R (1981) Amphetamine addiction and pregnancy: ii. pregnancy, delivery and the neonatal period. Socio-medical aspects. Acta Obstet Gynecol Scand 60:253–259 Eriksson M, Billing L, Steneroth G, Zetterstrom R (1989) Health and development of 8-Year-old children whose mothers abused amphetamine during pregnancy. Acta Paediatr 78:944–949 Eriksson M, Jonsson B, Steneroth G, Zetterström R (1994) Cross-sectional growth of children whose mothers abused amphetamines during pregnancy. Acta Paediatr 83:612–617 Eriksson M, Jonsson B, Steneroth G, Zetterström R (2000) Amphetamine abuse during pregnancy: Environmental factors and outcome after 14-15 years. Scand J Public Health 28:154–157 Flames N, Hobert O (2011) Transcriptional control of the terminal fate of monoaminergic neurons. Annu Rev Neurosci 34:153–184 Fox MD, Greicius M (2010) Clinical applications of resting state functional connectivity. Front Syst Neurosci 4:19 Frost DO, Cadet JL (2000) Effects of methamphetamine-induced neurotoxicity on the development of neural circuitry: a hypothesis. Brain Res Rev 34:103–118 Golub M, Costa L, Crofton K, Frank D, Fried P, Gladen B et al (2005) NTP-CERHR Expert Panel Report on the reproductive and developmental toxicity of amphetamine and methamphetamine. Birth Defects Res B Dev Reprod Toxicol 74:471–584 Gomes-da-Silva J, Pérez-Rosado A, Miguel R, Fernández-Ruiz J, Silva M, Tavares MA (2002) Prenatal Exposure to Methamphetamine in the Rat. Ann N Y Acad Sci 965:68–77 Graham D, Amos-Kroohs R, Braun A, Grace C, Schaefer T, Skelton M et al (2011) Long-term receptor alterations from developmental methamphetamine exposure in rats by use of selective pharmacological agonists and antagonists. Neurotoxicol Teratol 33:497–498 Graham DL, Amos-Kroohs RM, Braun AA, Grace CE, Schaefer TL, Skelton MR et al (2013) Neonatal (+)-methamphetamine exposure in rats alters adult locomotor responses to dopamine D1 and D2 agonists and to a glutamate NMDA receptor antagonist, but not to serotonin agonists. Int J Neuropsychopharmacol 16:377–391 Greicius MD, Krasnow B, Reiss AL, Menon V (2003) Functional connectivity in the resting brain: a network analysis of the default mode hypothesis. Proc Natl Acad Sci U S A 100:253–258 Helmich RC, Derikx LC, Bakker M, Scheeringa R, Bloem BR, Toni I (2010) Spatial remapping of cortico-striatal connectivity in Parkinson's disease. Cereb Cortex 20:1175–1186 Jedynak JP, Uslaner JM, Esteban JA, Robinson TE (2007) Methamphetamine-induced structural plasticity in the dorsal striatum. Eur J Neurosci 25:847–853 Jeng W, Wong AW, Ting-A-Kee R, Wells PG (2005) Methamphetamine-enhanced embryonic oxidative DNA damage and neurodevelopmental deficits. Free Radic Biol Med 39:317–326 Johnston MV, Ishida A, Ishida WN, Matsushita HB, Nishimura A, Tsuji M (2009) Plasticity and injury in the developing brain. Brain Dev 31:1–10 Kaewsuk S, Sae-ung K, Phansuwan-Pujito P, Govitrapong P (2009) Melatonin attenuates methamphetamine-induced reduction of tyrosine hydroxylase, synaptophysin and growth-associated protein-43 levels in the neonatal rat brain. Neurochem Int 55:397–405 Kaltenbach KA, Finnegan LP (1993) Studies of prenatal drug exposure and environmental research issues: the benefits of integrating research within a treatment program. NIDA Res Monogr 117:259–259 Khoshbouei H, Wang H, Lechleiter JD, Javitch JA, Galli A (2003) Amphetamine-induced dopamine efflux. A voltage-sensitive and intracellular Na + -dependent mechanism. J Biol Chem 278:12070 Kish SJ (2008) Pharmacologic mechanisms of crystal meth. CMAJ 178:1679–1682 Kreis R, Ernst T, Ross BD (1993) Absolute quantitation of water and metabolites in the human brain. II: metabolite concentrations. J Magn Reson 102:9–19 LaGasse LL, Wouldes T, Newman E, Smith LM, Shah RZ, Derauf C et al (2011) Prenatal methamphetamine exposure and neonatal neurobehavioral outcome in the USA and New Zealand. Neurotoxicol Teratol 33:166–175 LaGasse LL, Derauf C, Smith LM, Newman E, Shah R, Neal C et al (2012) Prenatal methamphetamine exposure and childhood behavior problems at 3 and 5 years of age. Pediatrics 129:681–688 Lester BM, Andreozzi L, Appiah L (2004) Substance use during pregnancy: time for policy to catch up with research. Harm Reduct J 1:5 Lewis SJ, Dove A, Robbins TW, Barker RA, Owen AM (2004) Striatal contributions to working memory: a functional magnetic resonance imaging study in humans. Eur J Neurosci 19:755–760 Little BB, Snell LM, Gilstrap LC (1988) Methamphetamine abuse during pregnancy: outcome and fetal effects. Obstet Gynecol 72:541–544 Lu LH, Johnson A, O’Hare ED, Bookheimer SY, Smith LM, O’Connor MJ, Sowell ER (2009) Effects of prenatal methamphetamine exposure on verbal memory revealed with fMRI. J Dev Behav Pediatr 30:185 Maisto SA, McKay JR, Connors GJ (1990) Self-report issues in substance abuse: State of the art and future directions. Behavioral Assessment 12:117–134 McKetin R, Kozel N, Douglas J et al (2008) The rise of methamphetamine in Southeast and East Asia. Drug and Alcohol Review 27:220–228 Melo P, Moreno VZ, Vázquez SP, Pinazo-Durán MD, Tavares MA (2006) Myelination changes in the rat optic nerve after prenatal exposure to methamphetamine. Brain Res 1106:21–29 Substance Abuse and Mental Health Services Administration (2010) Treatment episode data set (TEDS): 1998–2008. State admissions to substance abuse treatment services. DASIS Series: S-55 (HHS Publication No. SMA 10-4613). Rockville, MD: Author Meredith CW, Jaffe C, Ang-Lee K, Saxon AJ (2005) Implications of chronic methamphetamine use: A literature review. Harv Rev Psychiatry 13:141–154 Morrow BA, Roth RH, Redmond DE, Elsworth JD (2011) Impact of methamphetamine on dopamine neurons in primates is dependent on age: implications for development of Parkinson’s disease. Neurosci 189:277–285 Nguyen D, Smith LM, LaGasse LL, Derauf C, Grant P, Shah R et al (2010) Intrauterine growth of infants exposed to prenatal methamphetamine: results from the infant development, environment, and lifestyle study. J Pediatr 157:337–339 Nordahl TE, Salo R, Leamon M (2003) Neuropsychological effects of chronic methamphetamine use on neurotransmitters and cognition: A review. J Neuropsychiatry Clin Neurosci 15:317–325 Ondersma SJ, Simpson SM, Brestan EV, Ward M (2000) Prenatal drug exposure and social policy: the search for an appropriate response. Child Maltreat 5:93–108 Oro AS, Dixon SD (1987) Perinatal cocaine and methamphetamine exposure: maternal and neonatal correlates. J Pediatr 111:571–578 Poland ML, Dombrowski MP, Ager JW, Sokol RJ (1993) Punishing pregnant drug users: enhancing the flight from care. Drug Alcohol Depend 31:199–203 Roberts S, Nuru-Jeter A (2010) Women’s perspectives on screening for alcohol and drug use in prenatal care. Women Health Iss 20:193–200 Roussotte FF, Bramen JE, Nunez SC, Quandt LC, Smith L, O’Connor MJ et al (2011) Abnormal brain activation during working memory in children with prenatal exposure to drugs of abuse: the effects of methamphetamine, alcohol, and polydrug exposure. NeuroImage 54:3067–3075 Salisbury AL, Ponder KL, Padbury JF, Lester BM (2009) Fetal effects of psychoactive drugs. Clin Perinatol 36:595 Schmitz Y, Lee CJ, Schmauss C, Gonon F, Sulzer D (2001) Amphetamine distorts stimulation-dependent dopamine overflow: effects on D2 autoreceptors, transporters, and synaptic vesicle stores. J Neurosci 21:5916–5924 Scott JC, Woods SP, Matt GE, Meyer RA, Heaton RK, Atkinson JH, Grant I (2007) Neurocognitive effects of methamphetamine: a critical review and meta-analysis. Neuropsychol Rev 17:275–297 Semple SJ, Grant I, Patterson TL (2005) Female methamphetamine users: social characteristics and sexual risk behavior. Women & Health 40:35–50 Šlamberová R, Pometlová M, Charousová P (2006) Postnatal development of rat pups is altered by prenatal methamphetamine exposure. Prog Neuropsychopharmacol Biol Psychiatry 30:82–88 Smith LM, Chang L, Yonekura ML, Grob C, Osborn D, Ernst T (2001) Brain proton magnetic resonance spectroscopy in children exposed to methamphetamine in utero. Neurol 57:255–260 Smith LM, LaGasse LL, Derauf C, Grant P, Shah R, Arria A et al (2006) The infant development, environment, and lifestyle study: effects of prenatal methamphetamine exposure, polydrug exposure, and poverty on intrauterine growth. Pediatrics 118:1149–1156 Smith DK, Johnson AB, Pears KC, Fisher PA, DeGarmo DS (2007) Child maltreatment and foster care: unpacking the effects of prenatal and postnatal parental substance use. Child Maltreat 12:150–160 Smith LM, LaGasse LL, Derauf C, Grant P, Shah R, Arria A et al (2008) Prenatal methamphetamine use and neonatal neurobehavioral outcome. Neurotoxicol Teratol 30:20–28 Smith LM, LaGasse LL, Derauf C, Newman E, Shah R, Haning W et al (2011) Motor and cognitive outcomes through three years of age in children exposed to prenatal methamphetamine. Neurotoxicol Teratol 33:176–184 Sowell ER, Peterson BS, Thompson PM, Welcome SE, Henkenius AL, Toga AW (2003) Mapping cortical change across the human life span. Nat Neurosci 6:309–315 Sowell ER, Leow AD, Bookheimer SY, Smith LM, O’Connor MJ, Kan E et al (2010) Differentiating prenatal exposure to methamphetamine and alcohol versus alcohol and not methamphetamine using tensor-based brain morphometry and discriminant analysis. J Neurosci 30:3876–3885 Stanwood GD, Levitt P (2004) Drug exposure early in life: functional repercussions of changing neuropharmacology during sensitive periods of brain development. Curr Opin Pharmacol 4:65–71 Sulzer D, Sonders MS, Poulsen NW, Galli A (2005) Mechanisms of neurotransmitter release by amphetamines: a review. Prog Neurobiol 75:406–433 Suzuki T, Mizuo K, Nakazawa H, Funae Y, Fushiki S, Fukushima S et al (2003) Prenatal and neonatal exposure to bisphenol-A enhances the central dopamine D1 receptor-mediated action in mice: enhancement of the methamphetamine-induced abuse state. Neurosci 117:639–644 Terplan M, Smith EJ, Glavin SH (2010) Trends in injection drug use among pregnant women admitted into drug treatment: 1994–2006. J Womens Health 19:499–505 Thompson BL, Levitt P, Stanwood GD (2009) Prenatal exposure to drugs: effects on brain development and implications for policy and education. Nat Rev Neurosci 10:303–312 Twomey J, LaGasse L, Derauf C, Newman E, Shah R, Smith L et al (2013) Prenatal methamphetamine exposure, home environment, and primary caregiver risk factors predict child behavioral problems at 5 Years. Am J Orthopsychiatry 83:64–72 United Nations Office on Drugs, & Crime (2010) World Drug Report 2010. United Nations Publications United Nations Office on Drugs, and Crime (2013) World Drug Report 2013. United Nations Publications Vaccarino FM, Ment LR (2004) Injury and repair in developing brain. Arch Dis Child Fetal Neonatal Ed 89:190–192 Weiss K, Melkus G, Jakob PM, Faber C (2009) Quantitative in vivo (1)H spectroscopic imaging of metabolites in the early postnatal mouse brain at 17.6 T. MAGMA 22:53–62 Won L, Bubula N, McCoy H, Heller A (2001) Methamphetamine concentrations in fetal and maternal brain following prenatal exposure. Neurotoxicol Teratol 23:349–354 Wouldes TA, LaGasse LL, Derauf C, Newman E, Shah R, Smith LM et al (2013) Co-morbidity of substance use disorder and psychopathology in women who use methamphetamine during pregnancy in the US and New Zealand. Drug Alcohol Depend 127:101–107